Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Determination That Tovalt ODT (Zolpidem Tartrate) Orally Disintegrating Tablets, 5 Milligrams and 10 Milligrams

NoticeFDA_FRDOC_0001-14340
Comments
0
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
Document

Details

The document's own metadata, straight from the source system.

Title
Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Determination That Tovalt ODT (Zolpidem Tartrate) Orally Disintegrating Tablets, 5 Milligrams and 10 Milligrams
Posted
Jul 9, 2026
Comment period
Jul 9, 2026 – ?
FR Doc
2026-13820
Analysis

Overview

No comments yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.